[1] |
Zhang L, Zhou C, Zhang S,et al. Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors[J]. Front Oncol, 2022, 12:939249. DOI: 10.3389/fonc.2022.939249.
|
[2] |
Hiraoka N, Ino Y, Yamazaki-Itoh R. Tertiary lymphoid organs in cancer tissues[J]. Front Immunol, 2016, 7:244. DOI: 10.3389/fimmu.2016.00244.
|
[3] |
Zhang Q, Wu S. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response[J]. Front Immunol, 2023, 13:1063711. DOI: 10.3389/fimmu.2022.1063711.
|
[4] |
Almangush A, Bello IO, Elseragy A,et al. Tertiary lymphoid structures associate with improved survival in early oral tongue cancer[J]. BMC Cancer, 2022, 22(1):1108. DOI: 10.1186/s12885-022-10208-z.
|
[5] |
Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer[J]. Science, 2022, 375(6576):eabf9419. DOI: 10.1126/science.abf9419.
|
[6] |
Sautès-Fridman C, Petitprez F, Calderaro J,et al. Tertiary lymphoid structures in the era of cancer immunotherapy[J]. Nat Rev Cancer, 2019, 19(6):307-325. DOI: 10.1038/s41568-019-0144-6.
|
[7] |
Overacre-Delgoffe AE, Bumgarner HJ, Cillo AR,et al. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer[J]. Immunity, 2021, 54(12):2812-2824.e4. DOI: 10.1016/j.immuni.2021.11.003.
|
[8] |
Kroeger DR, Milne K, Nelson BH. Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures,cytolytic T-cell responses,and superior prognosis in ovarian cancer[J]. Clin Cancer Res, 2016, 22(12):3005-3015. DOI: 10.1158/1078-0432.CCR-15-2762.
|
[9] |
Hennequin A, Derangère V, Boidot R,et al. Tumor infiltration by Tbet + effector T cells and CD20 + B cells is associated with survival in gastric cancer patients[J]. Oncoimmunology, 2015, 5(2):e1054598. DOI: 10.1080/2162402X.2015.1054598.
|
[10] |
Goc J, Germain C, Vo-Bourgais TK,et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8 + T cells[J]. Cancer Res, 2014, 74(3):705-715. DOI: 10.1158/0008-5472.CAN-13-1342.
|
[11] |
di Caro G, Bergomas F, Grizzi F,et al. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers[J]. Clin Cancer Res, 2014, 20(8):2147-2158. DOI: 10.1158/1078-0432.CCR-13-2590.
|
[12] |
McMullen TP, Lai R, Dabbagh L,et al. Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules[J]. Clin Exp Immunol, 2010, 161(1):81-88. DOI: 10.1111/j.1365-2249.2010.04147.x.
|
[13] |
Baratin M, Simon L, Jorquera A,et al. T cell zone resident macrophages silently dispose of apoptotic cells in the lymph node[J]. Immunity, 2017, 47(2):349-362.e5. DOI: 10.1016/j.immuni.2017.07.019.
|
[14] |
Barone F, Gardner DH, Nayar S,et al. Stromal fibroblasts in tertiary lymphoid structures:A novel target in chronic inflammation[J]. Front Immunol, 2016, 7:477. DOI: 10.3389/fimmu.2016.00477.
|
[15] |
Ruffin AT, Cillo AR, Tabib T,et al. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma[J]. Nat Commun, 2021, 12(1):3349. DOI: 10.1038/s41467-021-23355-x.
|
[16] |
Ruddle NH. Lymphatic vessels and tertiary lymphoid organs[J]. J Clin Invest, 2014, 124(3):953-959. DOI: 10.1172/JCI71611.
|
[17] |
|
[18] |
Mebius RE. Organogenesis of lymphoid tissues[J]. Nat Rev Immunol, 2003, 3(4):292-303. DOI: 10.1038/nri1054.
|
[19] |
Luther SA, Bidgol A, Hargreaves DC,et al. Differing activities of homeostatic chemokines CCL19,CCL21,and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis[J]. J Immunol, 2002, 169(1):424-433. DOI: 10.4049/jimmunol.169.1.424.
|
[20] |
Deteix C, Attuil-Audenis V, Duthey A,et al. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection[J]. J Immunol, 2010, 184(9):5344-5351. DOI: 10.4049/jimmunol.0902999.
|
[21] |
Carrega P, Loiacono F, di Carlo E,et al. NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures[J]. Nat Commun, 2015, 6:8280. DOI: 10.1038/ncomms9280.
|
[22] |
Peske JD, Thompson ED, Gemta L,et al. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity[J]. Nat Commun, 2015, 6:7114. DOI: 10.1038/ncomms8114.
|
[23] |
Rodriguez AB, Peske JD, Woods AN,et al. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts[J]. Cell Rep, 2021, 36(3):109422. DOI: 10.1016/j.celrep.2021.109422.
|
[24] |
Lochner M, Ohnmacht C, Presley L,et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORγt and LTi cells[J]. J Exp Med, 2011, 208(1):125-134. DOI: 10.1084/jem.20100052.
|
[25] |
Guedj K, Khallou-Laschet J, Clement M,et al. M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis[J]. Cardiovasc Res, 2014, 101(3):434-443. DOI: 10.1093/cvr/cvt263.
|
[26] |
Munoz-Erazo L, Rhodes JL, Marion VC,et al. Tertiary lymphoid structures in cancer - considerations for patient prognosis[J]. Cell Mol Immunol, 2020, 17(6):570-575. DOI: 10.1038/s41423-020-0457-0.
|
[27] |
Li K, Guo Q, Zhang X,et al. Oral cancer-associated tertiary lymphoid structures:Gene expression profile and prognostic value[J]. Clin Exp Immunol, 2020, 199(2):172-181. DOI: 10.1111/cei.13389.
|
[28] |
Wang C, Huang Z, Zhang M,et al. Prognostic value of tertiary lymphoid structures in early clinical stage oral tongue squamous cell carcinoma[J]. J Oral Pathol Med, 2021, 50(8):776-784. DOI: 10.1111/jop.13215.
|
[29] |
Dieu-Nosjean MC, Goc J, Giraldo NA,et al. Tertiary lymphoid structures in cancer and beyond[J]. Trends Immunol, 2014, 35(11):571-580. DOI: 10.1016/j.it.2014.09.006.
|
[30] |
Heikkinen I, Bello IO, Wahab A,et al. Assessment of tumor-infiltrating lymphocytes predicts the behavior of early-stage oral tongue cancer[J]. Am J Surg Pathol, 2019, 43(10):1392-1396. DOI: 10.1097/PAS.0000000000001323.
|
[31] |
Wirsing AM, Rikardsen OG, Steigen SE,et al. Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma[J]. BMC Clin Pathol, 2014, 14:38. DOI: 10.1186/1472-6890-14-38.
|
[32] |
Nayar S, Campos J, Smith CG,et al. Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology[J]. Proc Natl Acad Sci U S A, 2019, 116(27):13490-13497. DOI: 10.1073/pnas.1905301116.
|
[33] |
Yamaguchi K, Ito M, Ohmura H,et al. Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer[J]. Oncoimmunology, 2020, 9(1):1724763. DOI: 10.1080/2162402X.2020.1724763.
|
[34] |
de Chaisemartin L, Goc J, Damotte D,et al. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer[J]. Cancer Res, 2011, 71(20):6391-6399. DOI: 10.1158/0008-5472.CAN-11-0952.
|
[35] |
Calderaro J, Petitprez F, Becht E,et al. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma[J]. J Hepatol, 2019, 70(1):58-65. DOI: 10.1016/j.jhep.2018.09.003.
|
[36] |
Tooley KA, Escobar G, Anderson AC. Spatial determinants of CD8 + T cell differentiation in cancer[J]. Trends Cancer, 2022, 8(8):642-654. DOI: 10.1016/j.trecan.2022.04.003.
|
[37] |
|
[38] |
Wirsing AM, Ervik IK, Seppola M,et al. Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma[J]. Mod Pathol, 2018, 31(6):910-922. DOI: 10.1038/s41379-018-0019-5.
|
[39] |
Peng Y, Xiao L, Rong H,et al. Single-cell profiling of tumor-infiltrating TCF1/TCF7 + T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures/organs and a superior prognosis in oral cancer[J]. Oral Oncol, 2021, 119:105348. DOI: 10.1016/j.oraloncology.2021.105348.
|
[40] |
Kadomoto S, Izumi K, Mizokami A. The CCL20-CCR6 axis in cancer progression[J]. Int J Mol Sci, 2020, 21(15):5186. DOI: 10.3390/ijms21155186.
|
[41] |
Bruno TC. New predictors for immunotherapy responses sharpen our view of the tumour microenvironment[J]. Nature, 2020, 577(7791):474-476. DOI: 10.1038/d41586-019-03943-0.
|
[42] |
Moyron-Quiroz JE, Rangel-Moreno J, Kusser K,et al. Role of inducible bronchus associated lymphoid tissue(iBALT)in respiratory immunity[J]. Nat Med, 2004, 10(9):927-934. DOI: 10.1038/nm1091.
|
[43] |
Rangel-Moreno J, Moyron-Quiroz JE, Hartson L,et al. Pulmonary expression of CXC chemokine ligand 13,CC chemokine ligand 19,and CC chemokine ligand 21 is essential for local immunity to influenza[J]. Proc Natl Acad Sci U S A, 2007, 104(25):10577-10582. DOI: 10.1073/pnas.0700591104.
|
[44] |
Moyron-Quiroz JE, Rangel-Moreno J, Hartson L,et al. Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs[J]. Immunity, 2006, 25(4):643-654. DOI: 10.1016/j.immuni.2006.08.022.
|
[45] |
Oliveira G, Stromhaug K, Klaeger S,et al. Phenotype,specificity and avidity of antitumour CD8 + T cells in melanoma[J]. Nature, 2021, 596(7870):119-125. DOI: 10.1038/s41586-021-03704-y.
|
[46] |
Buckley CD, Barone F, Nayar S,et al. Stromal cells in chronic inflammation and tertiary lymphoid organ formation[J]. Annu Rev Immunol, 2015, 33:715-745. DOI: 10.1146/annurev-immunol-032713-120252.
|
[47] |
Wang M, Zhai R, Wang M,et al. Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8 + T cells[J]. Mol Oncol, 2023 Feb 24. DOI: 10.1002/1878-0261.13403.
|
[48] |
Posch F, Silina K, Leibl S,et al. Maturation of tertiary lymphoid structures and recurrence of stage Ⅱ and Ⅲ colorectal cancer[J]. Oncoimmunology, 2017, 7(2):e1378844. DOI: 10.1080/2162402X.2017.1378844.
|
[49] |
Goc J, Fridman WH, Hammond SA,et al. Tertiary lymphoid structures in human lung cancers,a new driver of antitumor immune responses[J]. Oncoimmunology, 2014, 3:e28976. DOI: 10.4161/onci.28976.
|
[50] |
Hiraoka N, Ino Y, Yamazaki-Itoh R,et al. Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer[J]. Br J Cancer, 2015, 112(11):1782-1790. DOI: 10.1038/bjc.2015.145.
|
[51] |
Siliņa K, Rulle U, Kalniņa Z,et al. Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures:A novel anti-cancer treatment avenue?[J]. Cancer Immunol Immunother, 2014, 63(7):643-662. DOI: 10.1007/s00262-014-1544-9.
|
[52] |
Fridman WH, Zitvogel L, Sautès-Fridman C,et al. The immune contexture in cancer prognosis and treatment[J]. Nat Rev Clin Oncol, 2017, 14(12):717-734. DOI: 10.1038/nrclinonc.2017.101.
|
[53] |
Giraldo NA, Becht E, Pagès F,et al. Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer[J]. Clin Cancer Res, 2015, 21(13):3031-3040. DOI: 10.1158/1078-0432.CCR-14-2926.
|
[54] |
Li Q, Liu X, Wang D,et al. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma[J]. Int J Oral Sci, 2020, 12(1):24. DOI: 10.1038/s41368-020-00092-3.
|
[55] |
Helmink BA, Reddy SM, Gao J,et al. B cells and tertiary lymphoid structures promote immunotherapy response[J]. Nature, 2020, 577(7791):549-555. DOI: 10.1038/s41586-019-1922-8.
|